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Background. Carriage of multidrug resistant (MDR) Gram-negative bacteria (GN) in hospitalized neonates may increase the 
risk of difficult-to-treat invasive infections at neonatal intensive care units (NICUs). Data on MDRGN carriage among hospitalized 
newborns in Africa are limited.
Methods. We conducted a cross-sectional study at the NICUs of 2 tertiary hospitals in Ghana. Swabs from the axilla, groin, pe-
rianal region, and the environment were cultured, GN were identified, and antibiotic susceptibility was tested. We obtained blood 
culture isolates from neonates with sepsis. Whole-genome sequencing was used to characterize carbapenemase-producing Klebsiella 
pneumoniae. Typing was done by multilocus sequence typing (MLST) and single nucleotide polymorphism (SNP) analysis.
Results. A total of 276 GN were isolated from 228 screened neonates. Pathogenic GN were cultured in 76.8% (175 of 228) of 
neonates. Klebsiella spp (41.7%; 115 of 276) and Escherichia coli (26.4%; 73 of 276) were the commonest organisms. Carriage rates 
of MDRGN and third-generation cephalosporin resistant organisms were 49.6% (113 of 228) and 46.1% (105 of 228), respectively. 
Among Klebsiella spp, 75.6% (87 of 115) phenotypically expressed extended-spectrum β-lactamase activity, whereas 15.6% expressed 
carbapenemase and harbored bla-OXA-181 and bla-CTX-M-15. Overall, 7.0% (16 of 228) of neonates developed GN bloodstream infection. 
In 2 of 11 neonates, sequencing showed the same identity between carriage and the bloodstream isolate. Length of stay before spec-
imen collection and antibiotic use were independently associated with carriage rates, which increased from 13% at admission to 42% 
by day 2 and reached a plateau at 91% by day 15.
Conclusions. High carriage rates of MDRGN, including carbapenemase-producing enterobacterales may be an emerging 
problem in NICUs in Africa.
Keywords.  carbapenemase; carriage; Ghana; multidrug resistant; neonates.
There is an increase in the global burden of infections with 
multidrug-resistant Gram-negative bacteria (MDRGN) in neo-
nates, particularly in low-resource settings [1, 2]. Carriage of 
MDRGN, especially Klebsiella pneumoniae and Escherichia 
coli, is associated with late-onset neonatal bloodstream infec-
tions (BSIs) [3]. MDRGN can be transmitted from colonized 
individuals to other patients and persist in the environment 
due to poor infection prevention and control practices [4, 5]. 
MDRGN such as extended-spectrum β-lactamase (ESBL) and 
carbapenemase-producing enterobacterales have been associ-
ated with difficult-to-treat infections, increased length of hos-
pitalization, and increased risk of mortality [5, 6].
Screening critically ill patients for carriage of MDRGN helps 
in controlling the spread of antibiotic-resistant organisms [7] by 
allowing timely implementation of preventive measures [4, 8]. 
However, its usefulness in areas with endemic or rare occur-
rence of MDR organisms as well as its role in predicting sepsis 
remains controversial [9, 10].
In recent years, maternal-newborn interventions in low- and 
middle-income countries (LMICs) such as Ghana have led to 
more women giving birth in health facilities [11]. However, 
the infrastructural and human resources needed to provide 
effective hospital-based services are often deficient leading to 
overcrowding of neonatal intensive care units (NICUs) and in-
creased risk for healthcare-associated infections [12, 13]. Few 
studies have examined the carriage of MDRGN in NICUs in 
sub-Saharan Africa. Local data are critical for developing ev-
idence-based treatment guidelines and protocols for infection 
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prevention and control. In this cross-sectional study, we con-
ducted risk factor analysis for carriage of MDRGN and used 
whole-genome sequencing (WGS) to understand resistance 
mechanisms and sources of transmission in NICUs at 2 tertiary 
hospitals in Ghana.
MATERIALS AND METHODS
Study Design and Population
During the baseline period of an ongoing study evaluating infec-
tion control interventions against neonatal sepsis and MDRGN 
carriage (clinicaltrials.gov NCT03755635) [14], we conducted 
a cross-sectional study at the NICUs of 2 tertiary hospitals in 
Accra, Ghana. Data collection took place in September 2017 
and January 2018. This timeline was chosen to ensure that neo-
nates sampled the first time would have been discharged by the 
second sampling, thus reducing the chance of repeat sampling. 
Swabs were collected from all neonates on admission at the 
NICUs on a single day in September 2017 and in January 2018. 
To increase the proportion of newly admitted neonates in our 
dataset and thereby assess MDRGN carriage before admission, 
we collected swabs during the admission processes for a period 
of 14 days after the initial specimen collection.
Study Sites
The NICU at Korle-Bu Teaching hospital (KBTH) is a 55-bed 
facility, with 3 cubicles for high-dependency care and a 
5-bed kangaroo mother care ward. It admits approximately 
2400 neonates a year [15]. The 37 Military Hospital (37MH) 
NICU has 20 beds, it is divided into 3 cubicles, it and ad-
mits approximately 800 neonates annually. The first-line 
empiric antibiotic used for neonatal sepsis at the KBTH was 
cloxacillin and amikacin, whereas empiric antibiotics used 
for sepsis treatment at the 37MH varied. Routine screening 
for MDRGN carriage was not standard practice at the 2 hos-
pitals. Neonates were generally admitted on the day of birth 
usually without prior antibiotic administration. Thus, the mi-
crobiota of freshly admitted newborns is likely to reflect ma-
ternal microbiota.
Clinical Data
Clinical data extracted from patient records on the day of spec-
imen collection included maternal pregnancy history, birth 
weight, reason for admission, and antibiotic use before spec-
imen collection. Data on maternal receipt of antibiotics and 
group B Streptococcus carriage were not recorded, and we did 
not screen mothers for carriage of MDRGN.
Specimen Collection and Microbiology Analysis
Swabs were collected from neonates by a trained nurse using 
BBL culture swab liquid Amies Medium (Becton Dickinson, 
Franklin Lakes, NJ). Each sample was taken with a swab mois-
tened in transport medium and gently rotated in the fossa of the 
pinna, axilla, groin, and perianal region (in that order). These 
sites were chosen because of documented increased chance 
of isolating MDRGN [16]. All swabs were initially cultured 
on MacConkey agar plates at 35–37°C. Different GN colony 
morphotypes were identified and stored at −80°C and trans-
ported on dry ice to the Department of Clinical Microbiology, 
Rigshospitalet (Copenhagen, Denmark). Frozen isolates were 
thawed and cultured on lactose agar plates (SSI Diagnostica, 
Hillerød, Denmark) to recover GN, which were identified using 
MALDI Biotyper (Bruker Daltonics, Bremen, Germany).
During the study period, we conducted 3 environmental 
screenings at the KBTH (September 2017, October 2017, and 
January 2018, respectively) to understand the role of the envi-
ronment in the spread of MDRGN infections. Sites (incubator 
doors, cots, trolley handles, door handles, weighing scales, 
tables, and desks) were screened using Replicate Organism 
Detection and Count (RODAC) plates filled with tryptic soy 
agar for flat surfaces; for uneven surfaces, a swab was taken.
Antibiotic susceptibility testing was performed on Müller-
Hinton medium (SSI Diagnostica) by the Kirby Bauer disc 
diffusion method. All zone diameters were interpreted using 
European Committee on Antimicrobial Susceptibility Testing 
(EUCAST) breakpoints [17]. Zone sizes within the interme-
diate resistance and absolute resistant range were classified 
as resistant. All enterobacterales were assessed for ESBL, and 
isolates with a meropenem zone <28  mm were assessed for 
carbapenemase expression. These tests were performed and in-
terpreted according to EUCAST guidelines [18], using ROSCO 
(Taastrup, Denmark) phenotypic ESBL + AMPC and KPC + 
MBL + OXA-48 carbapenemase Kit. Multidrug resistance was 
defined as nonsusceptibility to ≥1 antibiotic in ≥3 antibiotic 
groups, with the following antibiotics used in the classification; 
gentamicin/amikacin, piperacillin tazobactam, meropenem, 
cefuroxime, cefotaxime, ciprofloxacin, and amoxicillin-
clavulanic acid [19].
Outcomes
Our primary outcome was the prevalence of GN carriage, in-
cluding antibiotic susceptibility. We further determined the 
proportion of neonates who developed GN BSI by reviewing 
data on blood cultures performed during hospitalization. Data 
on BSI and corresponding bacterial isolates were made available 
through an ongoing prospective study assessing neonatal sepsis 
at the 2 study sites (clinicaltrials.gov NCT03755635) [14].
Molecular Analysis
All K pneumoniae isolates with phenotypic carbapenemase 
production were whole-genome sequenced. Deoxyribonucleic 
acid (DNA) was purified with DNeasy Blood and Tissue kit 
(QIAGEN, Hilden, Germany). The isolates were sequenced 
on a MiSeq Instrument (Illumina Inc., San Diego, CA) using 
paired-end libraries (2 × 250 base pairs). Genome assemblies 
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were created with VelvetOptimiser v2.2.5 and annotated with 
Prokka v1.12.
In silico analyses of resistance genes, MLST  and capsular 
typing were performed using the online platform of the Centre 
for Genomic Epidemiology of the Danish Technical University 
and Kaptive  applying assemblies [20, 22]. To determine the 
source of BSI with K pneumoniae, we compared pairs of phe-
notypically similar isolates (carriage, bloodstream, and envi-
ronment) in a single nucleotide polymorphism (SNP) analysis 
using BacDist [23].
Data Availability
Raw reads for the 7 K pneumoniae genomes used in SNP anal-
ysis in this study are available in the European Nucleotide 
Archive (ENA) under the accession number PRJEB37523.
Statistical Analysis and Definitions
Data were analyzed with STATA (version 12; StataCorp). 
Categorical data were compared using χ 2 test, Z score for pro-
portions, and Wilcoxson rank-sum score for medians. Birth 
weight <2500 grams was classified as low birth weight. To iden-
tify factors associated with carriage of MDRGN as primary out-
come and carriage of third-generation cephalosporin resistance 
as secondary outcome, we generated univariate and multivar-
iate logistic regression models using the purposeful selection of 
covariates method [24]. We compared neonates with MDRGN 
with neonates who did not carry MDRGN, which included neo-
nates who did not culture a GN organism. All variables asso-
ciated with the outcome at a P < .2 in univariate analysis were 
included in multiple regression analysis. This was followed by 
an iterative process of purposeful removal of covariates in the 
multiple logistic regression based on their nonsignificance at 
P > .1. Confounders were then removed if they did not change 
parameter estimate by at least 15%. We present results as crude 
and adjusted odds ratio (OR) with 95% confidence intervals 
(CIs). Two-tailed P < .05 was considered significant.
Ethical Considerations
The study forms part of a larger project on neonatal sepsis given 
ethical approval by the Institutional Review Boards of KBTH 
(IRB/0025/2017) and 37MH (37MH-IRB IPN 144/2017). 
Informed consent was obtained from parents of neonates on ad-
mission. For day 1 or fresh admissions, administrative permis-
sion was sought to take swabs as part of the admission process. 
Carriage findings from the study were not disclosed to clinical 
staff or parents.
RESULTS
Patient Characteristics
During the 2 periods of sample collection, 228 neonates were 
assessed for GN carriage. Median duration of stay at time of 
specimen collection was 3  days (interquartile range [IQR], 
1–11). Mortality among the screened neonates was 9.6% (22 of 
228). Ninety-two (40.4%) samples were collected on the first 
day of admission. Table 1 describes the main characteristics of 
included neonates overall and by hospital.
Antibiotic Use
Of the screened neonates, 52% (118 of 228) had received anti-
biotic treatment before specimen collection. In total, 291 anti-
biotic prescriptions were made for 118 neonates. The median 
duration of antibiotic therapy at the time of data collection was 
8 days (IQR, 7–12). Most (73%, 86 of 118) had received a com-
bination of 2 (IQR, 2–3) antibiotics. The top 5 antibiotics used 
were cloxacillin (38.8%, 113 of 291), amikacin (35.4%, 103 of 
291), meropenem (8.2%, 24 of 291), ciprofloxacin (6.2%, 18 of 
291), and gentamicin (3.1%, 9 of 291) (Figure 1).
Carriage of Multidrug-Resistant Gram-Negative Bacteria
A total of 276 GN organisms were isolated from 76.8% (175 of 
228) neonates. Table 2 shows common organisms isolated and 
their respective antibiotic susceptibility patterns. The top 3 or-
ganisms isolated were Klebsiella spp (41.7%, 115 of 276), E coli 
(26.4%, 73 of 276), and Enterobacter spp (12.3%, 34 of 276).
Overall, the MDRGN carriage rate was 49.6% (113 of 228), 
whereas carriage of third-generation cephalosporin resistance 
was found in 46.1% (105 of 228) (Table 2). There was no sta-
tistically significant difference in the rate of MDRGN carriage 
between neonates admitted at KBTH (51.6%, 98 of 190)  and 
37MH (39.5%, 15 of 38) (P = .20). Multidrug-resistant was most 
common among Klebsiella spp (87.0%, 100 of 115), followed 
by Enterobacter spp (70.6%, 24 of 34) (Table 2). For the iden-
tified Klebsiella spp, resistance rates were 78.3% (90 of 115) to 
cefotaxime, followed by 65.2% (75 of 115)  to gentamicin and 
43.5% (50 of 115) to amikacin. Resistance rates of E coli were 
34.2% (25 of 73) to cefotaxime, 13.7% (10 of 73) to gentamicin, 
and 1.4% (1 of 73) to amikacin (Table 2).
Gram-negative bacteria in the environment
A total of 191 samples were taken from the KBTH NICU envi-
ronment for culture. Forty sites cultured a total of 47 GN organ-
isms. Fourteen (29.8%) of the organisms were K pneumoniae 
from the following sites: incubator doors (4); cots (9); and 
nurses trolley handle (1). The majority, 85.7% (12 of 14), were 
MDR, 78.6% (11 of 14)  were ESBL positive, and 21.4% (3 of 
14) were carbapenemase producing.
Resistance Mechanisms
Phenotypic expression of ESBL was found in 76.0% of 
Klebsiella spp and 32.8% of E coli. Among Klebsiella spp, 16.0% 
(18 of 115)  had meropenem zone <28  mm and were geno-
typic carbapenemase producers, carrying the carbapenemase 
bla-OXA-181 as well as ESBL bla-CTX-M-15. Thus, carriage rate of 
carbapenemase-producing Klebsiella spp was 7.9% (18 of 
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228). Carbapenemase-producing organisms were only found 
at KBTH.
Risk Factors for Carriage of Multidrug-Resistant Gram-Negative Bacteria
Antibiotic administration before specimen collection was as-
sociated with carriage of MDRGN in univariate (crude OR, 
15.0; 95% CI, 7.9–28.6) and multivariate analysis (adjusted OR 
[aOR], 11.1; 95% CI, 5.5–22.1) (Table  3). MDRGN carriage 
was also associated with duration of admission before spec-
imen collection in univariate (crude OR, 1.1; 95% CI, 1.05–
1.14) and multivariate (aOR, 1.04; 95% CI, 1.01–1.07) analysis. 
MDRGN carriage rate increased with duration of hospitaliza-
tion from 13% for neonates screened at day 1 of admission to 
42% by day 2, 47% by day 3, and reached a plateau at 91% by 
day 15 (Supplementary Figure 2). Carriage of third-generation 
cephalosporin-resistant organisms was associated with anti-
biotic use in univariate (crude OR, 16.10; 95% CI, 8.3–31.10) 
and multivariate analysis (aOR, 12.87; 95% CI, 6.41–25.8). The 
duration of stay before sampling was also associated with car-
riage of third-generation cephalosporin-resistant organisms 
in univariate (crude OR, 1.07; 95% CI, 1.04–1.10) and multi-
variate analysis (aOR, 1.02; 95% CI, 1.01–1.04) (Table  4). In 
subgroup analysis of neonates who had received antibiotics, 
the duration of antibiotic use was significantly associated with 
carriage of an MDR GN (aOR, 1.16; 95% CI, 1.03–1.30), ie, 
the odds of carrying an MDR GN increased 1.16 times for 
each day of antibiotic exposure (Supplementary Table S1). 
Likewise, duration of antibiotic use was independently associ-
ated with carriage of third-generation cephalosporin-resistant 
organisms among neonates on antibiotics (aOR, 1.19; 95% 
CI, 1.02–1.41) (Supplementary Table S2). Furthermore, in 
this subset of patients, low birth weight and vaginal delivery 
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Figure 1. Proportion of antibiotic type prescribed before specimen collection 
(n = 291).
Table 1. Sociodemographic and Clinical Characteristics of Neonates at Enrollmenta
Characteristics All Neonates (N = 228)
Neonates Enrolled 
From KBTH (N = 190)
Neonates Enrolled 
From 37MH (N = 38)
P 
Value
Age of mother, years 30.0 [25.0–35.0] 30 [25–35] 29 [23.5–34.5] .480
Parity 2.0 [2.0–3.0] 2 [1–3] 2 [1–3] .750
Number exposed to antibiotics at the 
time of sample collection
 118 [51.8] 98 [51.6] 20 [52.6] .910
Number of antibiotics prescribed 2.0 [2.0–3.0] 2 [2] 2 [2–3.8] .174
Duration of stay at the time of spec-
imen collection
3.0 [1.0–11.0] 3 [1–13] 2 [1–6] .146
Age at admission, median [IQR] (days) 1.0 [1.0–1.0] 1 [1] 1 [1] .865
Sex  N = 187 N = 36 .315
Male 113 [(50.7] 92 [49.2] 21 [58.3]  
Birth weight (grams)     
≥2500 101 [44.3] 76 [40.0] 25 [65.8] .003
1500–2400 73 [32.0] 63 [33.2] 10 [26.3] .820
1000–1400 45 [19.7] 42 [22.1] 3 [7.9]  
<1000 9 [4.0] 9 [4.7] 0 [0] -
Mode of delivery    N = 190 N = 36  
Caesarean section 123 [54.4] 100 [52.6] 23 [63.9] .210
Type of Birth    N = 187 N = 35  
Preterm 133 [59.9] 117 [62.6] 16 [45.7] .016
GN colonization 176 [77.2] 151 [79.5] 25 [65.8] .067
MDRGN colonization 113 [49.6] 98 [51.6] 15 [39.5] .170
GN BSI 16 [7%] 14 [7.4] 2 [5.3] -
Abbreviations: 37MH, 37 Military Hospital; BSI, bloodstream infection; GN, Gram-negative bacteria; IQR, interquartile range; KBTH, Korle-Bu Teaching Hospital; MDR, multidrug resistant. 
aData are presented as medians with IQRs and N [%] where appropriate; statistical level of significance set at P < .05.
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were independent risk factors for carriage of MDR and third-
generation cephalosporin-resistant GN.
Bloodstream Infections During Admission
During admission, 7.0% (16 of 228) of the neonates had GN BSI; 
13 (81.3%) were MDR, 11 (84.6%) of which were caused by ESBL-
producing K pneumoniae. Two (18.2%) of the neonates with BSI 
caused by ESBL-producing K pneumoniae were carriers of phe-
notypically similar organisms. The pairs were ST37/capsular type 
KL158 and ST37/capsular type KL15. In both cases, BSI had oc-
curred before swabs were taken. Single nucleotide polymorphism 
analysis of WGS data showed zero SNP difference between each 
carriage-bloodstream pair of isolates. The ST37 paired isolates 
(carriage/bloodstream) were closely related genetically to 3 envi-
ronmental K pneumoniae isolated 3 months before admission of 
the neonate with an SNP difference of 2–8.
DISCUSSION
The major finding of this study was a high rate of MDRGN 
carriage among neonates at 2 NICUs in Ghana. The car-
riage rate increased with duration of hospitalization and was 
Table 2. Antibiotic Resistance and Resistant Phenotypes Among Neonates With Carriage of Gram-negative Bacteriaa
Antibiotic
Klebsiella spp 
N = 115
Escherichia coli  
N = 73 (%)
Enterobacter spp  
N = 34
Pseudomonas 
aeruginosa N = 20
Acinetobacter spp  
N = 21
Citrobacter 
spp N = 4
Ampicillin 115 [100] 54 [74] 34 [100] - - 4 [100]
Amoxiclav 95 [82.6] 34 [46.6] 15 [44.1] - - 1 [75]
Gentamicin 75 [65.2] 10 [13.7] 16 [47.1] 3 [15.0] 11 [52.6] 0
Amikacin 50 [43.5] 1 [1.4] 14 [41.2] 0 7 [33.3] 0
Aztreonam 90 [78.6] 25 [34.2] 17 [50] 18 [90] - 1 [25]
Ceftazidime 91 [79.1] 23 [31.5] 17 [50] 3 [15.0] - 1 [25]
Cefotaxime 90 [78.3] 25 [34.2] 16 [47.1] - - 1 [25]
Cefuroxime 91 [79.1] 24 [32.9] 16 [47.1] - - 1 [25]
Ciprofloxacin 81 [70.4] 20 [27.4] 15 [44.1] 2 [10.0] 7 [33.3] 1 [25]
Mecillinam 7 [6.1] 1 [1.4] 3 [8.8]   1 [25]
Meropenemb 1 [.9] 0 0 2 [10.0] 7 [33.3] 0
Tazobactam piperacillin 41 [35.7] 9 [12.3] 8 [23.5] 3 [15.0]  1 [25]
MDR 100 [87.0] 40 [54.8] 24 [70.6] 3 [15] 7 [33.3] 2 [50]
ESBL phenotype 87 [75.6] 24 [32.8] - - - 0
Carbapenemase producing 18 [15.6] 0 0 - -  
Abbreviations: Acinetobacter spp, Acinetobacter baumannii-17, Acinetobacter nosocomialis-3, Acinetobacter iwoffi-1; carbapenemase producing, genotypic carbapenemase-producing organ-
isms; Citrobacter spp, Citrobacter koseri-3, Citrobacter freundii-1; Enterobacter spp, Enterobacter cloacae-22, Enterobacter kobei-6, Enterobacter aerogenes-4, Enterobacter hormaechiae-2, 
Enterobacter asburiae-1; ESBL phenotype, extended-spectrum β-lactamase-producing organisms; EUCAST, European Committee on Antimicrobial Susceptibility Testing; Klebsiella spp, 
Klebsiella pneumoniae-109, Klebsiella variicola-4, Klebsiella oxytoca-2; MDR, multidrug-resistant nonsusceptibility to ≥1 antibiotic in ≥3 antibiotic groups. 
aData are presented as N [%].
bCarbapenem resistance determined by EUCAST disc diffusion.
Table 3. Factors Associated With Carriage of Multidrug-Resistant Gram-Negative Bacteria in Neonates Admitted to Neonatal Intensive Care Unitsa
Characteristic
MDR GN Present 
[n = 113]
Crude Odds Ratio  
 [95% CI] P Value
Adjusted Odds 
Ratio [95% CI] P Value
Admitting weight (grams) ≥2500 47 [41.6] 1.00    
 1500–2499 35 [31.0] 1.06 [0.58–1.93] .854   
 1001–1499 24 [21.2] 1.31 [0.65–2.66] .448   
 ≤1000 7 [6.] 4.02 [0.80–20.31] .092   
Duration of stay before sample 
collection (days)
9.0 [4.0–22.0] 1.10 [1.05–1.14] <.001 1.04 [1.01–1.07] .023
Age of mother (years) 29.0 [24.0–35.0] 0.97 [0.93–1.01] .152   
Parity 1.0 [1.0–3.0] 0.83 [0.67–1.03] .092   
Sex Male 52 [46.0] 0.68 [0.40–1.16] .159   
Type of delivery Caesarean section 58 [51.3] 0.78 [0.46–1.32] .350   
Type of gestation Preterm 72 [64.9] 1.51 [0.88–2.60] 0.133   
Prolonged PROMb Yes 9 [10.4] 3.46 [0.72–16.62] .121   
Antibiotic Use Yes 92 [81.4] 15.00 [7.87–28.57] <.001 11.08 [5.54–22.15] <.001
Abbreviations: CI, confidence interval; GN, Gram negative; MDR, multidrug-resistant; PROM, premature rupture of membranes.
aData are presented as medians with interquartile ranges and n/N (%) where appropriate. Significant variables are presented in bold.
bStatistical level of significance set at P < .05.
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strongly associated with antibiotic use. Carriage of MDR 
Klebsiella spp, E coli, and Enterobacter spp was frequent; these 
isolates were resistant to universally recommended antibiotics 
(ampicillin, gentamicin) for empirical treatment of neonatal 
sepsis [25, 26]. In 2 neonates, we found an indication of pos-
sible endogenous BSI with MDR carriage organisms. This is 
in line with existing literature which shows that carriage of 
a drug-resistant organism is likely to serve as source of later 
infection [3].
To the best of our knowledge, this is the first report of 
blaOXA-181 carbapenemase-producing organisms in Ghana. OXA-
181 belongs to the OXA-48 type class D group of β-lactamases. 
These enzymes can hydrolyze penicillins at a high level and 
carbapenems at a low level but do not affect extended-spectrum 
cephalosporins and are not susceptible to most β-lactamase in-
hibitors [27].
Important reservoirs of OXA-48-type carbapenemases 
are countries in North Africa, the Middle East, Turkey, and 
India [28]; however, important reservoirs of OXA-181-type 
carbapenemases are in the Indian subcontinent [28]. In 
Africa, carbapenem resistance mediated by blaoxa-181 has been 
documented mainly in nonneonatal populations [29, 30]. In 
Morocco and Algeria, carriage of OXA-48 carbapenemase-
producing enterobacterales in neonates was 1.8% [31] and 
1.6%, respectively [32] compared with 7.9% found in our study. 
The relatively higher rate of OXA-181 in our study could indi-
cate a possible outbreak at the KBTH NICU.
Organisms expressing OXA-48-like carbapenemases are dif-
ficult to identify using routine phenotypic resistance testing 
methods [28]. This requires specialized but simple techniques, 
which may not be routinely available in laboratories in LMICs. 
We used EUCAST guidelines that have been found to be com-
parable to other methods for phenotypic identification of 
carbapenemase production [18, 33] and could be implemented 
in low-resource settings.
Similar to MDR, third-generation cephalosporin resistance 
was common among ESBL Klebsiella spp and E coli. These rates 
were higher compared to other reports from Africa [31]. In our 
recent multicenter study from Ghana, 64% antibiotic use was 
recorded among neonates, but cephalosporins (9.8%) were not 
commonly prescribed [34]. Our study corroborates the low use 
of these agents in neonates in Ghana. This suggests that other 
factors such as noncephalosporin antibiotic use, the NICU 
environment, and maternal colonization may play an impor-
tant role in the selection and transmission of cephalosporin-
resistant organisms.
In our study, we showed that invasive infection may have in-
volved endogenous microbiota of affected neonates as indicated 
in literature [3]. Our data further suggest the possible role of 
environmental persisting organisms such as K pneumoniae in 
carriage and infection.
Risk factors associated with carriage of MDR GN and 
third-generation cephalosporin-resistant enterobacterales in 
previous studies include prolonged exposure to antibiotics, 
increasing number of days of formula feeding, low birth 
weight, exposure to cephalosporins, prolonged hospitali-
zation, and use of invasive devices [32, 35]. In our setting, 
exposure to antibiotics and prolonged hospitalization were 
the main risk factors identified for carriage of MDR and 
third-generation cephalosporin-resistant GN. More than 
10% of neonates were colonized with MDRGN on arrival to 
the NICU. On the other hand, the fact that MDR coloniza-
tion took place within few days of admission in the majority 
of patients suggests that antimicrobial stewardship and en-
hanced infection prevention will be critical strategies for the 
control of MDRGN infections.
Table 4. Factors Associated With Carriage of Third-Generation Cephalosporin-Resistant Bacteria in Neonates Admitted at Neonatal Intensive Care Unitsa
Characteristic
3rd-Gen Present 
n = 105 Crude Odds Ratio [95% CI] P Value Adjusted Odds Ratio [95% CI] P Value
Admitting weight (g) ≥2500 44 [41.9] 1.00    
 1500–2499 32 [30.5] 1.01 [0.55–1.86] .972   
 1001–1499 22 [21.0] 1.24 [0.61–2.51] .551   
 ≤1000 7 [6.7] 4.53 [0.90–22.91] .067   
Duration of stay before specimen collection 
(days)
9.0 [4.0–22.0] 1.07 [1.04–1.10] <.001 1.02 [1.01–1.04] .044
Age of mother (years) 29.0 [24.0–35.0] 0.97 [0.93–1.02] .205   
Parity 1.0 [1.0–3.0] 0.84 [0.68–1.04] .111   
Sex Male 47 [44.8] 0.64 [0.38–1.08] .097   
Type of delivery Caesarean section 55 [52.4] 0.86 [0.51–1.44] .566 0.95 [0.49–1.83] .876
Type of gestation Preterm 68 [65.4] 1.54 [0.89–2.65] .119   
Prolonged PROMb Yes 8 [9.8] 2.31 [0.57–9.06] .231   
Antibiotic use Yes 88 [83.8] 16.05 [8.27–31.13] <.001  12.87 [6.41–25.83] <.001
Abbreviations: CI, confidence interval; GN, Gram negative; MDR, multidrug resistant; PROM, premature rupture of membranes; 3rd-Gen, third-generation cephalosporin.
aData are presented as medians with interquartile ranges and N (%) where appropriate. Significant variables are presented in boldface.
bStatistical level of significance set at P < .05.
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Neonatal intensive care units in low-resource settings face 
the challenge of low staff to patient ratio, limited space resulting 
in sharing of cots and incubators, and reuse of single-use de-
vices [36]. These practices may facilitate the spread of MDRGN 
among neonates with the possibility of outbreaks [37]. The high 
rates of carbapenemase-producing enterobacterales and ESBLs 
in the NICUs coupled with previously documented poor hand 
hygiene practices among healthcare workers in Ghana [38, 39] 
suggest that these organisms may also spread beyond NICUs if 
practices are not optimized.
Screening for MDRGN is previously found to be cost inten-
sive, resulting in excess use of antibiotics, and of limited benefit 
to patients in areas where MDRGN are rare or endemic [3, 10]. 
Thus, the usefulness of screening in low-resource settings with 
high prevalence of MDRGN has been questioned [31]. However, 
in the absence of routine diagnostic microbiology services to 
inform choice of antibiotics, screening may be useful to design 
rational empiric treatment policies. The current recommenda-
tions suggest that susceptibility to carbapenems should be re-
ported as found in enterobacterales with OXA-181 [18, 28], 
but its usefulness in treating such cases remains in doubt [28]. 
Other agents like colistin or ceftazidime-avibactam combin-
ations may be useful for managing these infections, although 
the cost may prohibit their use in low-resource settings.
This study has limitations. Specimens were collected at 2 different 
time periods, and context-specific interventions or events between 
the periods may have directly affected the carriage rate. In addi-
tion, empirical therapy for treating infections varied at both sites. 
The cross-sectional nature of the study does not allow for proper 
evaluation of associations between carriage of MDRGN and du-
ration of stay. We also did not have enough neonates who cultured 
GN organisms that were not MDR for comparison with MDRGN-
positive neonates. The carriage rates may have been underesti-
mated because recovery of GN is higher from rectal swabs than 
from perianal swabs [16], which were used in this study. The study 
was conducted in tertiary hospitals; thus, our findings may not be 
generalizable to nontertiary facilities. Nevertheless, this study high-
lights the role that MDRGN may play in NICUs in LMICs.
CONCLUSIONS
We found high external carriage of MDRGN among hospital-
ized neonates with high levels of resistance to recommended 
antibiotics for severe neonatal infections. Carbapenemase pro-
duction mediated by blaOXA-181 was found among K pneumoniae. 
There is a need to improve antibiotic use and infection control 
and prevention practices in NICUs to limit the potential impact 
of MDRGN in hospitalized neonates in low-resource settings.
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